15th Annual Reducing Cancer in Our Community: A Public Forum

Saturday, March 9, 2019

University Conference Center

Penn State Health Milton S. Hershey Medical Center/Penn State College of Medicine
30 Conference Drive
Hershey, PA 17033

More about the location

Select this button to navigate the sections of this page

Conference ID

D6307

Who Should Attend

Anyone with an interest in health-related issues is invited to attend, including patients and their families, patient advocate groups, teachers, and community leaders and organizations.

Topics

This year’s forum will cover three timely topics in oncology:

  • Hematologic malignancies
  • New cancer therapies
  • Breast cancer

Organizers

American Cancer Society

The American Cancer Society is the nationwide, community-based voluntary health organization dedicated to eliminating cancer as a major health problem by helping people stay well, helping people get well, finding cures and fighting back.

Penn State Cancer Institute

Penn State Cancer Institute is a partnership founded by Penn State Health Milton S. Hershey Medical Center, Penn State, Mount Nittany Medical Center and Penn State Health St. Joseph Medical Center, along with its affiliate members, UPMC Pinnacle Carlisle, UPMC Pinnacle Lancaster, Heart of Lancaster Regional Medical Center and UPMC Susquehanna. Penn State Cancer Institute is dedicated to prevention and treatment, improving care delivery, enhancing survivorship and quality of life for people living with cancer, and educating health care professionals, patients and caregivers in our communities.

Agenda

March 9, 2019, 8:30 a.m. to 2:15 p.m.

  • 8:30 a.m. | Check-In and Continental Breakfast
  • 9 a.m. | Welcome
    Andrea Manni, MD
    Professor of Medicine
    Chief, Division of Endocrinology, Diabetes and Metabolism
    Penn State Cancer Institute
  • 9:05 a.m. | Welcome from the American Cancer Society

Hematologic Malignancies

  • 9:15 a.m. | Leukemia
    David Claxton, MD
    Professor, Department of Medicine
    Penn State Cancer Institute
  • 9:35 a.m. | Lymphoma
    W. Christopher Ehmann, MD
    Professor, Department of Medicine
    Medical Director, Outpatient Clinics
    Penn State Cancer Institute
  • 9:55 a.m. | Pediatric Leukemia
    Sinisa Dovat, MD, PhD
    Professor and Vice Chair of Basic Science Research, Department of Pediatrics
    Professor, Department of Biochemistry and Molecular Biology
    Professor, Department of Pharmacology
    Penn State Cancer Institute
  • 10:15 a.m. | Q-and-A
  • 10:30 a.m. | Morning Break

New cancer therapies

  • 10:45 a.m. | Personalized Medicine
    James Broach, PhD
    Distinguished Professor and Chair
    Department of Biochemistry and Molecular Biology
    Director, Institute for Personalized Medicine
    Penn State Cancer Institute
  • 11:05 a.m. | Immunotherapy
    Todd Schell, PhD
    Professor, Department of Microbiology and Immunology
    Faculty Director, Flow Cytometry Core Facility
    Penn State Cancer Institute
  • 11:25 a.m. | Influence of Exercise in Cancer Prognosis and Treatment
    Kathryn Schmitz, PhD, MPH, FACSM, FTOS
    Professor, Department of Public Health Sciences
    Professor, Department of Physical Medicine and Rehabilitation
    Associate Director, Population Sciences
    Penn State Cancer Institute
  • 11:45 a.m. | Q-and-A
  • Noon | Lunch

Breast cancer

  • 1 p.m. | Patients, Policy and Purpose: The Impact of Cancer Advocacy in Pennsylvania
    Pat Halpin-Murphy, MS, MA
    Co-Chair, Patient Advocacy Committee of NRG Oncology Clinical Trial Organization
    Board Member, NSABP Foundation Clinical Trial Groups
    Chair, Pennsylvania Breast Cancer Coalition Research Grants Program
    President and Founder, Pennsylvania Breast Cancer Coalition
  • 2:15 p.m. | Adjournment

Faculty

James Broach, PhD
Distinguished Professor and Chair, Department of Biochemistry and Molecular Biology
Director, Institute for Personalized Medicine
Penn State Cancer Institute

David Claxton, MD
Professor, Department of Medicine
Penn State Cancer Institute

Sinisa Dovat, MD, PhD
Professor and Vice Chair of Basic Science Research, Department of Pediatrics
Professor, Department of Biochemistry and Molecular Biology
Professor, Department of Pharmacology
Penn State Cancer Institute

W. Christopher Ehmann, MD
Professor, Department of Medicine
Medical Director, Outpatient Clinics
Penn State Cancer Institute

Pat Halpin-Murphy, MS, MA
Co-Chair, Patient Advocacy Committee of NRG Oncology Clinical Trial Organization
Board Member, NSABP Foundation Clinical Trial Groups
Chair, Pennsylvania Breast Cancer Coalition Research Grants Program
President and Founder, Pennsylvania Breast Cancer Coalition

Andrea Manni, MD
Professor of Medicine
Chief, Division of Endocrinology, Diabetes and Metabolism
Penn State Cancer Institute

Todd Schell, PhD
Professor, Department of Microbiology and Immunology
Faculty Director, Flow Cytometry Core Facility
Penn State Cancer Institute

Kathryn Schmitz, PhD, MPH, FACSM, FTOS
Professor, Department of Public Health Sciences
Professor, Department of Physical Medicine and Rehabilitation
Associate Director, Population Sciences
Penn State Cancer Institute

Access (ADA)

Penn State encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of special accommodation or have questions about the physical access provided, please contact Continuing Education at least one week in advance of your participation or visit.

Changes

Content and speakers for all programs are subject to change. Registrants will be notified of any significant updates.

Disclosure and Conflict of Interest (COI and educational balance)

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants at the beginning of the activity.

University Nondiscrimination Policy

This publication is available in alternative media on request. The Pennsylvania State University is committed to the policy that all persons shall have equal access to programs, facilities, admission, and employment without regard to personal characteristics not related to ability, performance, or qualifications as determined by University policy or by state or federal authorities. It is the policy of the University to maintain an academic and work environment free of discrimination, including harassment. The Pennsylvania State University prohibits discrimination and harassment against any person because of age, ancestry, color, disability or handicap, genetic information, national origin, race, religious creed, sex, sexual orientation, gender identity, or veteran status and retaliation due to the reporting of discrimination or harassment. Discrimination, harassment, or retaliation against faculty, staff, or students will not be tolerated at The Pennsylvania State University. Direct all inquiries regarding the Nondiscrimination Policy to the Affirmative Action Director, The Pennsylvania State University, 328 Boucke Building, University Park, PA 16802-5901; tel 814-863-0471/TTY. US M.Ed. D6307

Jump to ...